Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page adds separate entries for the investigator and sponsoring institution (HW Kapiteijn and Leiden University Medical Center) and introduces new navigation links such as How to Read a Study Record, Common Questions, and How to Join a Study. It also updates the status/verification labels and changes the label formatting for Intervention/Treatment, plus updates the revision/version from v3.5.5 to v3.6.0.SummaryDifference1%

- Check19 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, reflecting a new metadata version of the page. This appears to be a minor maintenance update with no changes to the study details, eligibility criteria, or displayed content.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 was removed, updating the page's version label. This change updates the page's version indicator without altering substantive content.SummaryDifference0.1%

- Check62 days agoChange DetectedA footer “Revision” label was updated from v3.5.2 to v3.5.3, indicating a minor site or build version change rather than an update to the clinical study record.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision tag updated: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.